Cytokinetics News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.12.24	Sanofi To Buy Rights To Develop Cytokinetics' Aficamten In Greater China From Corxel (RTTNews)
02.12.24	Cytokinetics: FDA To Review NDA For Aficamten - Quick Facts (RTTNews)
09.09.24	Cytokinetics: Phase 1 Study Of CK-4021586 Meets Primary And Secondary Objectives (RTTNews)
11.01.24	Cytokinetics Stock Tanks 14% (RTTNews)
02.03.23	Pre-market Movers: MTC, SI, FNKO, OKTA, AEHR… (RTTNews)
29.01.23	Biotech Stocks Facing FDA Decision In February 2023 (RTTNews)
14.12.22	FDA Advisory Panel Votes Against Cytokinetics' Heart Drug (RTTNews)
28.11.22	Biotech Stocks Facing FDA Decision In December 2022 (RTTNews)
04.11.22	PRVB Awaits FDA's Decision, BCAB Soars On Clinical Trial Updates, CYTK Braces For Busy Months (RTTNews)
30.06.22	Cytokinetics Declines 8% Following $450 Mln Notes Offering (RTTNews)
11.01.21	Cytokinetics: CK-274 Receives Orphan Drug Designation - Quick Facts (RTTNews)
23.11.20	Amgen Terminates Collaboration With Cytokinetics On Omecamtiv Mecarbil And AMG 594 (RTTNews)
14.10.20	Pre-market Movers In Healthcare Sector: MDRX, TLC, HGEN, ENLV, BNTX, ATEC... (RTTNews)
08.10.20	Amgen: GALACTIC-HF Trial Meets Primary Composite Endpoint; Fails To Meet Secondary Endpoint (RTTNews)
05.10.20	Stock Alert: Cytokinetics Climbs 14% (RTTNews)
24.09.20	JNJ Begins Phase 3 COVID-19 Vaccine Trial, Another Headstone In Alzheimer's Graveyard, PFE On Watch (RTTNews)
08.05.20	Amgen:FDA Grants Fast Track Designation For Omecamtiv Mecarbil In Heart Failure (RTTNews)
24.02.20	Stock To Watch: One Down, One To Go For Cytokinetics (CYTK) (RTTNews)
22.09.18	Week Ahead In Pharmaceuticals: 10 Stocks To Watch (CKPT, SNDX, ADMP...) (RTTNews)
30.11.17	PTI Faces Busy December, CYTK Displays Fortitude, LENS Losing Sharpness? (RTTNews)
29.11.17	APEN Gains Steam, SGRY Starting To Heal, AZRX Catches Eyes, No Stopping CPRX (RTTNews)
22.11.17	OSUR Turns Heads, MRSN To Report Data By Year-end, CYTK Loses Vitality (RTTNews)
14.08.17	Stock Performance Review on Biotech Industry -- Blueprint Medicines, Calithera Biosciences, Concordia Intl., and Cytokinetics (PR Newswire)
04.08.17	Gainers & Losers Of Aug.3: OMED, OSUR, PACB, AGRX, ELGX... (RTTNews)
27.06.17	Daily Technical Summary Reports on Biotech Stocks -- Concordia, Cytokinetics, Dermira, and Endocyte (PR Newswire)
09.05.17	FDA Snubs TXMD, AGRX To Try Luck Again, CYTK Abuzz, ROKA Surges After-Hours (RTTNews)
26.04.17	Las Vegas Sands Reports First Quarter 2017 Results (PR Newswire)
19.04.17	Gainers & Losers Of Apr.18: XOMA, AKTX, CYTK, AGIO, SRNE... (RTTNews)
18.04.17	Gigamon, CBL & Associates Properties and Cytokinetics Set to Join S&P SmallCap 600 (PR Newswire)
01.12.16	The Lancet Publishes Results From COSMIC-HF Trial Showing Omecamtiv Mecarbil Significantly Improved Cardiac Function In Patients With Chronic Heart Failure (PR Newswire)
13.05.15	Cytokinetics to Hold Annual Meeting of Stockholders (GlobeNewswire)
16.04.15	Cytokinetics to Announce First Quarter Results on April 30, 2015 (GlobeNewswire)
08.04.15	Cytokinetics to Present at the 14th Annual Needham Healthcare Conference (GlobeNewswire)
25.03.15	Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis (GlobeNewswire)
13.03.15	Cytokinetics Announces Completion of Enrollment in COSMIC-HF (GlobeNewswire)
27.02.15	Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases (GlobeNewswire)
26.02.15	Cytokinetics Announces Publication of Preclinical Data Relating to CK-2127107 and Exercise Tolerance in Rodent Model of Heart Failure (GlobeNewswire)
24.02.15	Cytokinetics to Present at Healthcare Conferences in March (GlobeNewswire)
23.12.14	Cytokinetics and Astellas Announce Expansion of Collaboration for Development of CK-2127107 in Spinal Muscular Atrophy and Other Neuromuscular Indications (GlobeNewswire)
05.12.14	Cytokinetics Announces Presentations Relating to Tirasemtiv and Effects on Respiratory Muscle Function at International Symposium on ALS/MND (GlobeNewswire)
01.12.14	Cytokinetics Announces Presentations Relating to Tirasemtiv at the 25th International Symposium on ALS/MND (GlobeNewswire)
26.11.14	Cytokinetics to Participate in the 26th Annual Piper Jaffray Healthcare Conference (GlobeNewswire)
10.11.14	Cytokinetics' President & CEO Robert Blum Receives 2014 Lou Gehrig Iron Horse Award From ALS Therapy Development Institute (GlobeNewswire)
27.10.14	Cytokinetics Provides Development Program Update for Omecamtiv Mecarbil (GlobeNewswire)
20.10.14	Cytokinetics Provides Development Program Update for Tirasemtiv (GlobeNewswire)
16.10.14	Cytokinetics to Announce Third Quarter Results on October 30, 2014 (GlobeNewswire)
13.10.14	Cytokinetics Announces Development Program Update for CK-2127107 (GlobeNewswire)
07.08.14	Cytokinetics to Present at the 34th Annual Canaccord Global Growth Conference (GlobeNewswire)
16.07.14	Cytokinetics to Announce Second Quarter Results on July 30, 2014 (GlobeNewswire)
10.07.14	Cytokinetics Announced Additional Results Relating to Tirasemtiv from Pre-Specificed Subgroup Analyses of BENEFIT-ALS (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Cytokinetics Inc

Aktien Top/Flop

Cytokinetics Peer Group Nachrichten

Meistgelesene Nachrichten